Interspecies scaling: predicting clearance of drugs in humans. Three different approaches
- PMID: 8893036
- DOI: 10.3109/00498259609052491
Interspecies scaling: predicting clearance of drugs in humans. Three different approaches
Abstract
1. The interspecies scaling approach to predict clearance in humans from animal data was tested for a wide variety of drugs. 2. Three different methods were utilized to generate plots to scale-up the clearance values: (i) method I, clearance versus body weight (simple allometric equation); (ii) method II, product of clearance and maximum life-span potential; (iii) method III, product of clearance and brain weight versus body weight. 3. The circumstances under which the three methods can be applied to predict clearance in humans were evaluated. 4. If the exponent lies between 0.55 to 0.7 then method I predicts clearance reasonably well. 5. If the exponent lies between 0.71 to 1.0 clearance can be predicted reasonably well by method II. 6. If the exponent is > 1.0 clearance can be predicted using method III.
Similar articles
-
Interspecies scaling: role of protein binding in the prediction of clearance from animals to humans.J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1439-46. J Clin Pharmacol. 2000. PMID: 11185664
-
Interspecies scaling and comparisons in drug development and toxicokinetics.Xenobiotica. 1990 Nov;20(11):1201-31. doi: 10.3109/00498259009046839. Xenobiotica. 1990. PMID: 2275215 Review.
-
Interspecies scaling: predicting clearance of anticancer drugs in humans. A comparative study of three different approaches using body weight or body surface area.Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):275-8. doi: 10.1007/BF03189726. Eur J Drug Metab Pharmacokinet. 1996. PMID: 8980928
-
Interspecies scaling: predicting oral clearance in humans.Am J Ther. 2002 Jan-Feb;9(1):35-42. doi: 10.1097/00045391-200201000-00008. Am J Ther. 2002. PMID: 11782818
-
Interspecies allometric scaling. Part I: prediction of clearance in large animals.J Vet Pharmacol Ther. 2006 Oct;29(5):415-23. doi: 10.1111/j.1365-2885.2006.00786.x. J Vet Pharmacol Ther. 2006. PMID: 16958787 Review.
Cited by
-
Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.J Clin Pharmacol. 2013 Mar;53(3):276-84. doi: 10.1002/jcph.8. Epub 2013 Feb 13. J Clin Pharmacol. 2013. PMID: 23408495 Free PMC article. Clinical Trial.
-
Interspecies modeling and prediction of human exenatide pharmacokinetics.Pharm Res. 2013 Mar;30(3):751-60. doi: 10.1007/s11095-012-0917-z. Epub 2012 Nov 15. Pharm Res. 2013. PMID: 23229855 Free PMC article.
-
Preclinical pharmacokinetic characterization of amdizalisib, a novel PI3Kδ inhibitor for the treatment of hematological malignancies.Front Pharmacol. 2024 Jun 14;15:1392209. doi: 10.3389/fphar.2024.1392209. eCollection 2024. Front Pharmacol. 2024. PMID: 38948472 Free PMC article.
-
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs.Xenobiotica. 2011 Nov;41(11):972-87. doi: 10.3109/00498254.2011.598582. Epub 2011 Sep 5. Xenobiotica. 2011. PMID: 21892879 Free PMC article.
-
Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety.Psychopharmacology (Berl). 2008 Aug;199(3):389-402. doi: 10.1007/s00213-008-1096-9. Epub 2008 Mar 6. Psychopharmacology (Berl). 2008. PMID: 18322676 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources